medigraphic.com
Instituto Nacional de Salud Pública

2007, Number S3

<< Back Next >>

salud publica mex 2007; 49 (S3)

Prevalence of HIV infection among adult population in Mexico: an increasingly expanding epidemic

Valdespino JL, García-García ML, Conde-González CJ, Olaiz-Fernández G, Palma O, Sepúlveda J

Language: Spanish
References: 68
Page: 386-394
PDF size: 230.59 Kb.


ABSTRACT

Objective. UNAIDS has recognized that estimating HIV infection at a national or regional level is important for evaluation, program planning and advocacy. Following this recommendation, the purpose of this study was to estimate the magnitude of HIV infection prevalence among adults from the general population using information from the National Health Survey (ENSA 2000), a probabilistic, multi-stage, stratified, cluster household survey conducted by the Mexican Ministry of Health between November 1999 and June 2000. Availability of information from the Seroepidemiological Survey conducted in 1987 allowed for the estimation of trends between the two surveys (1987-2000). Material and Methods. A total of 21 271 males and females 20 years or older included in the ENSA 2000 were randomly selected and studied for anti-HIV 1/2 IgG (ELISA), confirmed by immunoelectrotransference (WB), and for risk factors associated with HIV infection. Samples were processed in the National Institute of Public Health in 2005. Results. Prevalence for HIV infection was 0.25%. The main factors associated with infection were younger ages, male gender, residence in the Federal District, college education or higher, and being single or divorced. Conclusions. Seroprevalence among adults shows a ten-fold increase as compared with the results of the national seroprevalence survey of 1987. Although the epidemic continues to be concentrated among men who have sex with men, results provide evidence of dissemination towards the heterosexual population.


REFERENCES

  1. UNAIDS. AIDS Epidemic Update. December 2005. Ginebra: UNAIDS, 2005.

  2. Centro Nacional para la Prevención y el Control del VIH/SIDA. El SIDA en cifras. México: CENSIDA, 2005.

  3. Sector Salud. Situación del SIDA en Mexico. Datos actualizados hasta el 1 de diciembre de 1987. Dirección General de Epidemiología. Boletín Mensual de SIDA 1987;1(10):192-200.

  4. Consejo Nacional para la Prevención y Control del VIH/SIDA. Panorama Epidemiológico del VIH/SIDA e ITS en México. 31 de diciembre de 2004. DF, México: CENSIDA, 2004.

  5. Sepulveda-Amor J, del Río-Zolezzi A, Valdespino-Gómez JL, García-García M L, Velázquez-Velázquez L, Volkow P. The strategy for preventing HIV/AIDS transmission via the blood and its derivatives in Mexico. Salud Publica Mex 1995;37(6):624-35.

  6. Magis-Rodríguez C. Estudio sobre practicas de riesgo de infección por VIH/SIDA en inyectores de drogas de la Cd. de Tijuana, BC. Rev Salud Front 1997;2:31-14.

  7. Valdespino-Gómez JL, García-García M L, del Río-Zolezzi A, Loo-Méndez E, Magis-Rodríguez C, Salcedo-Álvarez RA. The epidemiology of AIDS/HIV in Mexico: from 1983 to March 1995. Salud Publica Mex 1995;37(6):556-71.

  8. McQuillan GM, Khare M, Karon JM, Schable CA, Vlahov D. Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14(4):355-60.

  9. UNAIDS/WHO. Working Group on Global HIV/AIDS and STI surveillance. Guidelines for measuring national HIV prevalence in population-based surveys. Ginebra: UNAIDS/WHO, 2005.

  10. Valdespino JL, Olaiz G, Mendoza L, Palma O, Velazquez O, et al. Encuesta Nacional de Salud 2000. Tomo 1. Vivienda, población y utilización de servicios de salud. Cuernavaca, México: Instituto Nacional de Salud Pública, 2003.

  11. Interpretation and use of the western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989;38(Suppl 7):1-7.

  12. Ley de Información Estadística y Geográfica. Diario Oficial de la Federación, 30 de diciembre, 1980.

  13. Ramiro-Cruz J. Medicina transfusional en los países del Caribe y Lationamérica, 2000-2003. (THS/EV-2005/005-E). Washington,DC: Organización Panamericana de la Salud; 2005.

  14. Vázquez-Flores J, Valiente-Banuet L, Marín L, Sánchez-Guerrero A. La seguridad de las reservas sanguíneas en la República Mexicana durante los años 1999 a 2003. Rev Inves Clin 2006;58(2): 101-108.

  15. Guerra-Márquez A. El VIH/SIDA y la mujer. Atención familiar (Órgano informativo del Departamento de Medicina Familiar) 2002;9(3).

  16. Vera-Gamboa L, Gongora-Biachi R, Pavia-Ruiz N, Gaber-Osorno J, Lara-Perera D, Alonzo-Salomon L. Aceptabilidad para la detección de anticuerpos contra el VIH en un grupo de mujeres embarazadas de Yucatán, México. Ginecol Obstet Mex 2005;73(7):355-359.

  17. Arredondo-García J, Hernández-Trejo M, Figueroa-Damián R, Ortiz-Ibarra F, Ahued-Ahued J. SIDA y embarazo. Ginecol Obstet Mex 1997;66:8-12.

  18. Izazola-Licea JA, Ávila-Figueroa RC, Gortmaker SL, del Río-Chiriboga C. The homosexual transmission of HIV/AIDS in Mexico. Salud Publica Mex 1995;37(6):602-14.

  19. Medina-Mora ME, Cravioto P, Villatoro J, Fleiz C, Galvan-Castillo F, Tapia-Conyer R. Drugs use among adolescents: results from the National Survey on Addictions, 1998. Salud Publica Mex 2003;45 (Suppl 1):S16-25.

  20. Magis-Rodríguez C, Ruiz-Badillo A, Ortiz-Mondragón R, Loya-Sepúlveda M, Bravo-Portela M, Lozada-Romero R. Estudio sobre prácticas de riesgo de infección para VIH/SIDA en inyectores de drogas de la ciudad de Tijuana B.C. Biblioteca Virtual en Salud México. DF: México: ONUSIDA, 1997.

  21. Guerena-Burgueno F, Benenson AS, Sepulveda-Amor J. HIV-1 prevalence in selected Tijuana sub-populations. Am J Public Health 1991;81(5):623-5.

  22. Magis-Rodríguez C, Brouwer KC, Morales S, Gayet C, Lozada R, Ortiz-Mondragon R, et al. HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana. J Psychoactive Drugs 2005;37(3):333-9.

  23. Rodríguez CM, Marques LF, Touze G. HIV and injection drug use in Latin America. Aids 2002;16 Suppl 3:S34-41.

  24. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Tomo 2. La salud de los adultos. Cuernavaca, México: Instituto Nacional de Salud Pública, 2003.

  25. Alvarado-Esquivel C, Sablon E, Martínez-García S, Estrada-Martínez S. Hepatitis virus and HIV infections in inmates of a state correctional facility in Mexico. Epidemiol Infect 2005;133(4):679-85.

  26. Izazola-Licea S, Labastida-Díaz A, Villanueva-Castilleja R. La situación actual de VIH/SIDA en prisiones en México. MEXICO, D.F.: SIDALAC; 1998.

  27. Olivero J, Roberts J. AIDS in Mexican prisons. AIDS Soc 1995;6(4):4.

  28. Sexual abuse in children and HIV infection (Abs. #M.D.P. 7). V International Conference on AIDS; 1989; Montreal, Canada.

  29. Viloria-Varela G, Montero P. Grupos vulnerables de la Ciudad de México. Entrevista al Diputado por la Asamblea Legislativa del Distrito Federal, Juan Díaz González. Imagen Política de México y el Mundo, 9 de octubre, 2002.

  30. Del Río C, Sepulveda J. AIDS in Mexico: lessons learned and implications for developing countries. Aids 2002;16(11):1445-57.

  31. Villasis-Keever A, Rangel-Frausto MS, Ruiz-Palacios G, Ponce de Leon-Rosales S. Clinical manifestations and survival trends during the first 12 years of the AIDS epidemic in Mexico. Arch Med Res 2001;32(1):62-5.

  32. Cámara de Diputados. 59 Legislatura. Centro de Estudios Sociales y de Opinión Pública. Cifras de mortalidad en México, 2003.

  33. Secretaría de Salud. Sistema Nacional de Información en Salud. Mortalidad, 2004.

  34. Varela-Ramírez A, Mejía A, García D, Bader J, Aguilera RJ. HIV infection and risk behavior of Hispanic farm workers at the west Texas-Mexico border. Ethn Dis 2005;15(4 Suppl 5):S5: 92-6.

  35. Tapia-Aguirre V, Arillo-Santillán E, Allen B, Angeles-Llerenas A, Cruz-Valdez A, Lazcano-Ponce E. Associations among condom use, sexual behavior, and knowledge about HIV/AIDS. A study of 13,293 public school students. Arch Med Res 2004;35(4):334-43.

  36. Martínez-Donate AP, Hovell MF, Blumberg EJ, Zellner JA, Sipan CL, Shillington AM, et al. Gender differences in condom-related behaviors and attitudes among Mexican adolescents living on the U.S.-Mexico border. AIDS Educ Prev 2004;16(2):172-86.

  37. Allen B, Cruz-Valdez A, Rivera-Rivera L, Castro R, Arana-García ME, Hernández-Ávila M. Affection, kisses, and condoms: the ABC of sexual practices of female sex workers in Mexico City. Salud Publica Mex 2003;45(Supp 5):S594-607.

  38. Pulerwitz J, Izazola-Licea JA, Gortmaker SL. Extrarelational sex among Mexican men and their partners’ risk of HIV and other sexually transmitted diseases. Am J Public Health 2001;91(10):1650-2.

  39. Gutiérrez JP, López-Zaragoza JL, Valencia-Mendoza A, Pesqueira E, Ponce-de-Leon S, Bertozzi SM. [Facing the HIV/AIDS epidemic in Mexico: the response of the health sector]. Rev Invest Clin 2004;56(2):242-52.

  40. Izazola-Licea JA, Ávila-Figueroa C, Aran D, Piola S, Perdomo R, Hernández P, et al. Country response to HIV/AIDS: national health accounts on HIV/AIDS in Brazil, Guatemala, Honduras, Mexico and Uruguay. Aids 2002;16(Suppl 3):S66-75.

  41. Grmek MD. The concept of emerging disease. Hist Philos Life Sci 1993;15(3):281-296.

  42. Centers for Disease Control and Prevention. Hepatitis C what clinicians and other health professionals need to know. Atlanta: USCDC, 2001.

  43. Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003;52(RR-3):1-13, 15; quiz CE1-4.

  44. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements 2002;19(3):1-46.

  45. Vázquez-Flores J, Valiente-Banuet L, Marín L, Sánchez-Guerrero A. La seguridad de las reservas sanguíneas en la República Mexicana durante los años 1999 a 2003. Rev Inves Clin 2006;58(2): 101-108.

  46. Varela-Ramírez A, Mejía A, García D, Bader J, Aguilera RJ. HIV infection and risk behavior of Hispanic farm workers at the west Texas-Mexico border. Ethn Dis 2005;15(4 Suppl 5):S5-92-96.

  47. Tapia-Aguirre V, Arillo-Santillán E, Allen B, Angeles-Llerenas A, Cruz-Valdez A, Lazcano-Ponce E. Associations among condom use, sexual behavior, and knowledge about HIV/AIDS. A study of 13,293 public school students. Arch Med Res 2004;35(4):334-343.

  48. Allen B, Cruz-Valdez A, Rivera-Rivera L, Castro R, Arana-Garcia ME, Hernandez-Avila M. Affection, kisses, and condoms: the ABC of sexual practices of female sex workers in Mexico City. Salud Publica Mex 2003;45 Supp 5:S594-S607.

  49. Pulerwitz J, Izazola-Licea JA, Gortmaker SL. Extrarelational sex among Mexican men and their partners’ risk of HIV and other sexually transmitted diseases. Am J Public Health 2001;91(10):1650-1652.

  50. Programa de Acción, México. Sistema Nacional de Vigilancia Epidemiológica. En: Salud Sd, ed. Sistema Nacional de Vigilancia Epidemiológica. México: Secretaría de Salud, 2001.

  51. Rivera-López MR, Zavala-Méndez C, Arenas-Esqueda A. Prevalence for seropositivity for HIV, hepatitis B and hepatitis C in blood donors. Gac Med Mex 2004;140(6):657-660.

  52. Carreto-Vélez MA, Carrada-Bravo T, Martínez-Magdaleno A. Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico. Salud Publica Mex 2003;45 Supp 5:S690-S693.

  53. Vivas-Arceo C, Benavides SA, De Jesus-Trujillo J, Panduro A, Rivas-Estilla AM. Hepatitis C virus: prevalence and routes of infection among blood donors of West Mexico. Hepatol Res 2003;25(2):115-123.

  54. Ladrón-de Guevara L, Gómez N, Vazquez-Cantarell M, García-Méndez S, Di Silvio M. Prevalence of and risk factors for hepatitis C in blood donors. Rev Gastroenterol Mex 2002;67(1):11-16.

  55. Ayala Gaytan JJ, Guerra Avalos FJ, Mora Brondo P, Casillas Romo A. Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico. Rev Gastroenterol Mex 1997;62(4):250-253.

  56. Guerrero-Romero JF, Castañeda A, Rodríguez-Morán M. Prevalence of risk factors associated with hepatitis C in blood donors in the municipality of Durango, Mexico. Salud Publica Mex 1996;38(2):94-100.

  57. Merino-Conde E, Orozco JA, Rojo-Medina J, Tovar A. Prevalence of hepatitis C virus among candidates for blood donation at the Hospital General de Mexico. In Vivo 1994;8(4):621-623.

  58. Méndez-Sánchez N, Baptista-González H, Sánchez-Gómez RH, Bordes-Aznar J, Uribe-Esquivel M. The prevalence of hepatitis B and C in blood donors in a 3rd-level hospital of Mexico City. Salud Publica Mex 1999;41(6):475-678.

  59. Redlinger TE, O’Rourke K, Magana J, Steege A. Hepatitis B and C among adolescents at an STD clinic on the US-Mexico border. Tex Med 2001;97(10):52-56.

  60. Méndez-Sánchez N, Motola-Kuba D, Chávez-Tapia NC, Bahena J, Correa-Rotter R, Uribe M. Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico. J Clin Microbiol 2004;42(9):4321-4322.

  61. González-Michaca L, Mercado A, Gamba G. Viral C hepatitis in patients with end stage renal disease. II. Viral genotypes. Rev Invest Clin 2000;52(5):491-496.

  62. López RA, Romero-Estrella S, Infante-Ramírez L, Méndez-Aquino JS, Berron-Ruiz P, Morales-Alfaro NA, et al. Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form. Transfusion 2004;44(9):1344-1349.

  63. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341(8):556-562.

  64. Ley de Información Estadística y Geográfica. México: Diario Oficial de la Federación; diciembre 30, 1980.

  65. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144(10):705-714.

  66. Vera-de León L, Juárez-Navarro JA, Díaz-Gómez M, Méndez-Navarro J, Chirino-Sprung RA, Dehesa-Violante M, et al. Epidemiologic and situational panorama of hepatitis C in Mexico. Rev Gastroenterol Mex 2005;70(1):25-32.

  67. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Tomo 2, La salud de los adultos. Cuernavaca, México: Instituto Nacional de Salud Pública, 2003.

  68. Svendsen RN, Kofod S. Distribution of free equipment to intravenous drug addicts in Copenhagen. Ugeskr Laeger 1993;155(4):227-231.




2020     |     www.medigraphic.com